RDNT vs. FTRE, GH, VCYT, CSTL, FLGT, CDNA, BDSX, BNR, PSNL, and RNLX
Should you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fortrea (FTRE), Guardant Health (GH), Veracyte (VCYT), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), CareDx (CDNA), Biodesix (BDSX), Burning Rock Biotech (BNR), Personalis (PSNL), and Renalytix (RNLX). These companies are all part of the "medical laboratories" industry.
RadNet (NASDAQ:RDNT) and Fortrea (NASDAQ:FTRE) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation, risk and community ranking.
RadNet has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.
RadNet received 333 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 65.70% of users gave RadNet an outperform vote while only 47.06% of users gave Fortrea an outperform vote.
In the previous week, Fortrea had 23 more articles in the media than RadNet. MarketBeat recorded 35 mentions for Fortrea and 12 mentions for RadNet. RadNet's average media sentiment score of 0.39 beat Fortrea's score of 0.37 indicating that RadNet is being referred to more favorably in the media.
RadNet currently has a consensus price target of $57.25, suggesting a potential downside of 0.35%. Fortrea has a consensus price target of $35.57, suggesting a potential upside of 29.12%. Given Fortrea's higher possible upside, analysts plainly believe Fortrea is more favorable than RadNet.
RadNet has a net margin of 1.28% compared to Fortrea's net margin of -4.11%. RadNet's return on equity of 5.05% beat Fortrea's return on equity.
77.9% of RadNet shares are held by institutional investors. 4.4% of RadNet shares are held by insiders. Comparatively, 0.1% of Fortrea shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
RadNet beats Fortrea on 12 of the 18 factors compared between the two stocks.
Get RadNet News Delivered to You Automatically
Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
